0001179110-19-010082.txt : 20190904
0001179110-19-010082.hdr.sgml : 20190904
20190904170544
ACCESSION NUMBER: 0001179110-19-010082
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190830
FILED AS OF DATE: 20190904
DATE AS OF CHANGE: 20190904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goss Michael L
CENTRAL INDEX KEY: 0001783472
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36269
FILM NUMBER: 191075332
MAIL ADDRESS:
STREET 1: 77 FOURTH AVE., 5TH FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Care.com Inc
CENTRAL INDEX KEY: 0001412270
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200]
IRS NUMBER: 205785879
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 77 FOURTH AVENUE
STREET 2: 5TH FLOOR
CITY: Waltham
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781 642 5900
MAIL ADDRESS:
STREET 1: 77 FOURTH AVENUE
STREET 2: 5TH FLOOR
CITY: Waltham
STATE: MA
ZIP: 02451
3
1
edgar.xml
FORM 3 -
X0206
3
2019-08-30
0
0001412270
Care.com Inc
CRCM
0001783472
Goss Michael L
C/O CARE.COM, INC.
77 FOURTH AVENUE, 5TH FLOOR
WALTHAM
MA
02451
0
1
0
0
Acting Chief Financial Officer
Common Stock, $0.001 par value
3161
D
Restricted Stock Units
Common Stock
1399
D
Restricted Stock Units
Common Stock
2114
D
Restricted Stock Units
Common Stock
915
D
Restricted Stock Units
Common Stock
2889
D
Restricted Stock Units
Common Stock
634
D
Restricted Stock Units
Common Stock
4020
D
Options (Right to Buy)
6.70
Common Stock
5832
D
Options (Right to Buy)
12.01
Common Stock
6334
D
The restricted stock units will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
The restricted stock units will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
The restricted stock units will vest as to 33.33% of the original grant on February 26, 2018 and as to an additional 16.67% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
The restricted stock units will vest as to 6.25% of the original grant on June 9, 2018 and at the end of each successive three month period thereafter until March 9, 2022, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
The restricted stock units will vest as to 50% of the original grant on March 9, 2019 and as to an additional 12.5% at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
The restricted stock units will vest as to 6.25% of the original grant on June 9, 2019 and at the end of each successive three month period thereafter until March 9, 2023, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The restricted stock units have no expiration date.
The options will vest as to 6.25% of the original grant on June 9, 2016 and at the end of each successive three month period thereafter until March 9, 2020, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 10, 2026.
The options will vest as to 6.25% of the original grant on June 9, 2017 and at the end of each successive three month period thereafter until March 9, 2021, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date. The options will expire on March 15, 2027.
/s/ Melanie Goins, as Attorney-in-Fact for Michael Goss
2019-09-04